Related Experiment Video

Updated: May 29, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in

Paula Vainio1, Maija Wolf, Henrik Edgren

  • 1Turku Centre for Biotechnology, University of Turku, Turku, Finland.

The Prostate
|September 16, 2011
PubMed
Abstract

Insights

Researchers identified FAM110B as a key gene promoting castration-resistant prostate cancer (CRPC) growth. Silencing FAM110B inhibited cancer cell proliferation, highlighting it as a potential therapeutic target for CRPC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Castration-resistant prostate cancer (CRPC) presents significant challenges in treatment.
  • Current therapeutic options for CRPC are limited, necessitating the identification of novel targets.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying CRPC progression.
  • To identify novel therapeutic targets for CRPC by analyzing genetic and gene expression data.

Main Methods:

  • Utilized array-comparative genomic hybridization (array-CGH) and gene expression microarrays on CRPC and advanced tumor samples.
  • Integrated genome-wide DNA and RNA data to pinpoint amplified and overexpressed genes.
  • Employed RNA interference (siRNA) to silence candidate genes in prostate cancer cells and assessed functional roles.

Main Results:

  • Identified six recurrent genetic targets in CRPC: ATP1B1, AR, FAM110B, LAS1L, MYC, and YIPF6.
  • FAM110B was identified as a key gene driving CRPC progression in a subset of tumors, regulating androgen receptor (AR) signaling.
  • FAM110B siRNA significantly inhibited prostate cancer cell growth in vitro, particularly under androgen-deficient conditions.

Conclusions:

  • FAM110B was identified as a potential growth-promoting gene in CRPC through integrated DNA/RNA analysis and functional assays.
  • FAM110B plays a crucial role in androgen signaling and CRPC progression, impacting multiple cancer hallmarks.
  • FAM110B represents a promising therapeutic target for castration-resistant prostate cancer.

More Related Videos

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...